Immunotec Inc. (IMMTF) Financials Nov 14, 2014, 8:
Post# of 250675
Posted On: 11/17/2014 2:58:47 AM
Immunotec Inc. (IMMTF) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Immunotec Inc.
Fiscal year is November-October. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 44.72M 40.34M 42.92M 49.21M 54.77M
Cost of Goods Sold (COGS) incl. D&A 9.08M 8.92M 31.63M 36.68M 41.09M
COGS excluding D&A 8M 7.73M 30.46M 35.73M 40.28M
Depreciation & Amortization Expense 1.08M 1.19M 1.17M 946,060 814,174
Depreciation 537,881 596,468 540,586 386,797 402,264
Amortization of Intangibles 541,848 596,634 629,673 559,263 411,910
Gross Income 35.65M 31.42M 11.29M 12.53M 13.68M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 37.31M 12.12M 11.87M 11.83M 12.35M
Research & Development 946,790 1.18M 905,113 866,010 887,724
Other SG&A 36.36M 10.94M 10.97M 10.97M 11.47M
Other Operating Expense 36,099 20.1M 0 142,716 0
Unusual Expense 1.17M 749,794 635,326 455,983 716,951
EBIT after Unusual Expense (1.17M) (749,794) (635,326) (455,983) (716,951)
Non Operating Income/Expense 0 59,015 (66,199) (5,594) 145,819
Non-Operating Interest Income - - - 4,241 -
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 155,610 84,101 81,650
Gross Interest Expense 0 0 155,610 84,101 81,650
Interest Capitalized 0 0 0 0 0
Pretax Income (2.87M) (1.5M) (1.44M) 8,390 671,511
Income Tax (196,888) (327,531) (386,344) (117,017) (705,763)
Income Tax - Current Domestic 39,789 98,180 93,605 8,462 291,855
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (236,677) (425,711) (479,949) (7,759) (569,497)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 117,720 428,121
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income (2.67M) (1.17M) (1.05M) 125,407 1.38M
Minority Interest Expense 0 0 0 0 0
Net Income (2.67M) (1.17M) (1.05M) 125,407 1.38M
Extraordinaries & Discontinued Operations (1.87M) (219,621) (50,000) 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - - -
Discontinued Operations (1.87M) (219,621) (50,000) 0 0
Net Income After Extraordinaries (4.55M) (1.39M) (1.1M) 125,407 1.38M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.67M) (1.17M) (1.05M) 125,407 1.38M
EPS (Basic) (0.07) (0.02) (0.02) 0.00 0.02
Basic Shares Outstanding 69.99M 69.99M 69.99M 69.99M 69.6M
EPS (Diluted) (0.07) (0.02) (0.02) 0.00 0.02
Diluted Shares Outstanding 69.99M 69.99M 69.99M 69.99M 69.6M
EBITDA (617,701) 388,811 589,148 1.5M 2.14M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Immunotec Inc.
Fiscal year is November-October. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 44.72M 40.34M 42.92M 49.21M 54.77M
Cost of Goods Sold (COGS) incl. D&A 9.08M 8.92M 31.63M 36.68M 41.09M
COGS excluding D&A 8M 7.73M 30.46M 35.73M 40.28M
Depreciation & Amortization Expense 1.08M 1.19M 1.17M 946,060 814,174
Depreciation 537,881 596,468 540,586 386,797 402,264
Amortization of Intangibles 541,848 596,634 629,673 559,263 411,910
Gross Income 35.65M 31.42M 11.29M 12.53M 13.68M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 37.31M 12.12M 11.87M 11.83M 12.35M
Research & Development 946,790 1.18M 905,113 866,010 887,724
Other SG&A 36.36M 10.94M 10.97M 10.97M 11.47M
Other Operating Expense 36,099 20.1M 0 142,716 0
Unusual Expense 1.17M 749,794 635,326 455,983 716,951
EBIT after Unusual Expense (1.17M) (749,794) (635,326) (455,983) (716,951)
Non Operating Income/Expense 0 59,015 (66,199) (5,594) 145,819
Non-Operating Interest Income - - - 4,241 -
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 155,610 84,101 81,650
Gross Interest Expense 0 0 155,610 84,101 81,650
Interest Capitalized 0 0 0 0 0
Pretax Income (2.87M) (1.5M) (1.44M) 8,390 671,511
Income Tax (196,888) (327,531) (386,344) (117,017) (705,763)
Income Tax - Current Domestic 39,789 98,180 93,605 8,462 291,855
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (236,677) (425,711) (479,949) (7,759) (569,497)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 117,720 428,121
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income (2.67M) (1.17M) (1.05M) 125,407 1.38M
Minority Interest Expense 0 0 0 0 0
Net Income (2.67M) (1.17M) (1.05M) 125,407 1.38M
Extraordinaries & Discontinued Operations (1.87M) (219,621) (50,000) 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - - -
Discontinued Operations (1.87M) (219,621) (50,000) 0 0
Net Income After Extraordinaries (4.55M) (1.39M) (1.1M) 125,407 1.38M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.67M) (1.17M) (1.05M) 125,407 1.38M
EPS (Basic) (0.07) (0.02) (0.02) 0.00 0.02
Basic Shares Outstanding 69.99M 69.99M 69.99M 69.99M 69.6M
EPS (Diluted) (0.07) (0.02) (0.02) 0.00 0.02
Diluted Shares Outstanding 69.99M 69.99M 69.99M 69.99M 69.6M
EBITDA (617,701) 388,811 589,148 1.5M 2.14M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)